DOI 10.1186/s12987-026-00825-2
Acute amyloid-β exposure disrupts insulin signaling in hCMEC/D3 blood-brain barrier endothelial cells.
Аннотация
BACKGROUND
Brain insulin resistance and cerebrovascular dysfunction emerge early in late-onset Alzheimer's disease, but how amyloid-β (Aβ) disrupts insulin signaling at the cerebrovascular blood-brain barrier-a major site of insulin receptor signaling and transport into the brain-remains unclear.
METHODS
We exposed two distinct human blood-brain-barrier endothelial cell models to soluble Aβ40 or Aβ42 for 1 h, followed by 100 nM insulin for 10 min. Protein and phosphoprotein responses were quantified by reverse-phase protein array, and differential expression was evaluated using linear models.
RESULTS
In hCMEC/D3 cells, Aβ40 reduced insulin-stimulated Akt activation and converted insulin's normal inhibition of AMPK into modest stimulation. Aβ42 did not alter insulin-stimulated Akt signaling but moderately suppressed basal Akt activation. Because the iBMEC model did not show insulin-induced activation of PI3K-Akt signaling, mechanistic interpretation of Aβ effects on insulin-responsive signaling focused on hCMEC/D3 cells.
CONCLUSIONS
These findings identify acute Aβ40-sensitive impairment of insulin-responsive Akt signaling in hCMEC/D3 BBB endothelial cells. The results define candidate signaling nodes for further mechanistic study of Aβ effects on BBB insulin-signaling dysfunction.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.